Atlas Trials

Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy

Clinical trial NCT00070174 · COMPLETED

Trial details

NCT number
NCT00070174
Sponsor
Children's Oncology Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
2003-12-01
Primary completion
2006-09-01
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.